SiteMap
Alzheimer
Brain diseases
Research
Tau
APP
Abeta
VCDN group
flag

Aging

ALS

ALS/PDC Guam
AGD
Bri
CBD
DLDH
DM1
Down Syndrome
GSS
FTD
FTDP-17
Huntington
Hallenvorden
IBM
Lewy BD
MSA
NPiD c
Parkinson Dementia Guadeloupe
Parkinson
Dementia  in Parkinson 
Pick
Prion
PSP
PEP
Semantic  Dementia
SSP
  ToD

Biochemical staging of tau pathology

 

At stage 10 all cortical brain areas, as well as many subcortical areas, are affected by tau pathology. The patient is always severely demented.

The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Delacourte et al. Neurology. 1999 Apr 12;52(6):1158-65.

 

  1. Stage 0
  2. Stage1
  3. Stage 2
  4. Stage 3
  5. Stage 4
  6. Stage 5
  7. Stage 6
  8. Stage 7
  9. Stage 8
  10. Stage 9
  11. Stage 10

Having understood the pathway of tauopathy in the human brain affected by Alzheimer's disease, the main question is to know what is the fuel of tauopathy in AD, as well as in other tauopathies.

 

For AD, following the amyloid cascade hypothesis (ACH), we expect to see huge amounts of amyloid in the brain of patient decades or years before the first tau aggregates.

For the "believers" of ACH or the bAPPtists, we recommend not to see what is happening in the human brain, and to continue to believe in the mouse brain, peacefully.


Accueil   Liens  vers sites apparentés   Lexique Map of site
Plan du site